Top compounds associated with response to CHRD


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.06
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC 0.066 0.07
mRNA spautin-1 CTRPv2 pan-cancer AAC 0.067 0.07
mRNA NSC 74859 CTRPv2 pan-cancer AAC -0.068 0.07
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.07
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC 0.092 0.08
mRNA lapatinib gCSI pan-cancer AAC -0.097 0.08
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.08
mRNA MI-2 CTRPv2 pan-cancer AAC 0.091 0.08
mRNA RO4929097 CTRPv2 pan-cancer AAC 0.091 0.08
Download CSV